This report provides updated prevalence of HIV infection and behaviors since the last NHBS
survey among persons who inject drugs in 2012 (3).
, Quarterly Report-Southern District, January-March 1957
An Q, Song R, Finlayson TJ, Wejnert C, Paz-Bailey G; NHBS
data ([paragraph][paragraph][paragraph]) indicate that, although the percentage of PWID in 22 cities who received syringes from a syringe services program (SSP) *** (9) increased during 2005-2015 for all racial/ethnic groups (p<0.
In 2012, NHBS
data indicated that 9% of persons who inject drugs tested positive for HIV, and among those persons, 36% were unaware of their infection before testing (2).
In 2012, NHBS
staff collected cross-sectional behavioral survey data and conducted HIV testing among PWID recruited using respondent-driven sampling * (2-4) in 20 cities ([dagger]) with high prevalence of acquired immunodeficiency syndrome (AIDS).
Data from NHBS
([dagger]) were used to describe adjusted trends in unprotected anal sex ([section]) in the past 12 months among MSM in 2005, 2008, and 2011.
35% in NHANES, 7%-20% in NHBS
, an estimated 4%-8% in NHSS, and 9% in MMP.
8% of participants had never been tested for HIV until the NHBS
monitors HIV-associated behaviors and HIV prevalence among populations at high risk for acquiring HIV.
However, among MSM in NHBS
who had been tested for HIV within the past 12 months, the prevalence of undiagnosed HIV among MSM who reported these high-risk behaviors (7%) was similar to that among those who did not (8%) (6).
This report summarizes data collected from heterosexuals in 24 MSAs with a high prevalence of acquired immunodeficiency syndrome (AIDS) that participated in NHBS